PubMed

Extended oral anticoagulant therapy after a first episode of pulmonary embolism.

Agnelli G, Prandoni P, Becattini C, Silingardi M, Taliani MR, Miccio M, Imberti D, Poggio R, Ageno W, Pogliani E, Porro F, Zonzin P; Warfarin Optimal Duration Italian Trial Investigators.

Ann Intern Med. 2003 Jul 1;139(1):19-25.PMID: 12834314 [PubMed - indexed for MEDLINE]Related articlesFree article

Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.

Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, Moia M, Guazzaloca G, Bertoldi A, Tomasi C, Scannapieco G, Ageno W; Warfarin Optimal Duration Italian Trial Investigators.

N Engl J Med. 2001 Jul 19;345(3):165-9.PMID: 11463010 [PubMed - indexed for MEDLINE]Related articlesFree article

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, Turpie AG, Green D, Ginsberg JS, Wells P, MacKinnon B, Julian JA.

N Engl J Med. 1999 Mar 25;340(12):901-7. Erratum in: N Engl J Med 1999 Jul 22;341(4):298. PMID: 10089183 [PubMed - indexed for MEDLINE]Related articlesFree article

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

Schulman S, Granqvist S, Holmström M, Carlsson A, Lindmarker P, Nicol P, Eklund SG, Nordlander S, Lärfars G, Leijd B, Linder O, Loogna E.

N Engl J Med. 1997 Feb 6;336(6):393-8.PMID: 9010144 [PubMed - indexed for MEDLINE]Related articlesFree article

The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism.

Douketis JD, Gu CS, Schulman S, Ghirarduzzi A, Pengo V, Prandoni P.

Ann Intern Med. 2007 Dec 4;147(11):766-74.PMID: 18056660 [PubMed - indexed for MEDLINE]Related articlesFree article

Anticoagulation period in idiopathic venous thromboembolism. How long is enough?

Farraj RS.

Saudi Med J. 2004 Jul;25(7):848-51.PMID: 15235686 [PubMed - indexed for MEDLINE]Related articles

Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial.

Campbell IA, Bentley DP, Prescott RJ, Routledge PA, Shetty HG, Williamson IJ.

BMJ. 2007 Mar 31;334(7595):674. Epub 2007 Feb 8.PMID: 17289685 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.

Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA, MacKinnon B, Weitz JI, Crowther MA, Dolan S, Turpie AG, Geerts W, Solymoss S, van Nguyen P, Demers C, Kahn SR, Kassis J, Rodger M, Hambleton J, Gent M; Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators.

N Engl J Med. 2003 Aug 14;349(7):631-9.PMID: 12917299 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of DVT: how long is enough and how do you predict recurrence.

Agnelli G, Becattini C.

J Thromb Thrombolysis. 2008 Feb;25(1):37-44. Epub 2007 Oct 1. Review.PMID: 17906973 [PubMed - indexed for MEDLINE]Related articles

[Prolongation of anti vitamin K treatment for 18 months versus placebo after 6 months treatment of a first episode of ideopathic pulmonary embolism: a mutlicentre, randomised double blind trail. The PADIS-EP Trial]

Couturaud F, Pernod G, Pison C, Mismetti P, Sanchez O, Meyer G, Parent F, Girard P, Simonneau G, Drouet L, Gueret P, Jego P, Delaval P, Duhamel E, Gruel Y, Delahousse B, Regina S, Pottier P, Connaud J, Lecomte F, Provost K, Vilmans N, Gosset X, Bura-Rivière A, Meach G, Lacut K, Bosson JL, Guillot K, Mottier D, Leroyer C.

Rev Mal Respir. 2008 Sep;25(7):885-93. French. PMID: 18946418 [PubMed - indexed for MEDLINE]Related articles

Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis.

Pinede L, Ninet J, Duhaut P, Chabaud S, Demolombe-Rague S, Durieu I, Nony P, Sanson C, Boissel JP; Investigators of the "Durée Optimale du Traitement AntiVitamines K" (DOTAVK) Study.

Circulation. 2001 May 22;103(20):2453-60.PMID: 11369685 [PubMed - indexed for MEDLINE]Related articlesFree article

Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation.

Taliani MR, Agnelli G, Prandoni P, Becattini C, Moia M, Bazzan M, Ageno W, Tomasi C, Guazzaloca G, Ambrosio GB, Bertoldi A, Salvi R, Poggio R, Silingardi M; Warfarin Optimal Duration Italian Trial (WODIT) Investigators.

J Thromb Haemost. 2003 Aug;1(8):1730-3.PMID: 12911585 [PubMed - indexed for MEDLINE]Related articles

D-dimer testing to determine the duration of anticoagulation therapy.

Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, Pengo V, Ghirarduzzi A, Pattacini C, Testa S, Lensing AW, Tripodi A; PROLONG Investigators.

N Engl J Med. 2006 Oct 26;355(17):1780-9. Erratum in: N Engl J Med. 2006 Dec 28;355(26):2797. PMID: 17065639 [PubMed - indexed for MEDLINE]Related articlesFree article

A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Lärfars G, Nicol P, Loogna E, Svensson E, Ljungberg B, Walter H.

N Engl J Med. 1995 Jun 22;332(25):1661-5.PMID: 7760866 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor.

Kearon C, Ginsberg JS, Anderson DR, Kovacs MJ, Wells P, Julian JA, Mackinnon B, Demers C, Douketis J, Turpie AG, Van Nguyen P, Green D, Kassis J, Kahn SR, Solymoss S, Desjardins L, Geerts W, Johnston M, Weitz JI, Hirsh J, Gent M; SOFAST Investigators.

J Thromb Haemost. 2004 May;2(5):743-9.PMID: 15099280 [PubMed - indexed for MEDLINE]Related articles

Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Pinede L, Ninet J, Duhaut P et al for the Investigators of the 'Durée Optimale du Traitement Antivitamines K' (DOTAVK) study. Circulation 2001; 103: 2453-60.

Anand SS.

Vasc Med. 2001 Nov;6(4):269-70.PMID: 11958396 [PubMed - indexed for MEDLINE]Related articles

Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy.

Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, Solymoss S, Crowther M, Perrier A, White R, Vickars L, Ramsay T, Betancourt MT, Kovacs MJ.

CMAJ. 2008 Aug 26;179(5):417-26.PMID: 18725614 [PubMed - indexed for MEDLINE]Related articlesFree article

[Duration of oral anticoagulant therapy in venous thromboembolism]

Pinède L.

Rev Med Interne. 2001 Dec;22(12):1225-36. Review. French. PMID: 11794893 [PubMed - indexed for MEDLINE]Related articles

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.

Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ; PREVENT Investigators.

N Engl J Med. 2003 Apr 10;348(15):1425-34. Epub 2003 Feb 24.PMID: 12601075 [PubMed - indexed for MEDLINE]Related articlesFree article

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.

Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Musolesi S.

Lancet. 1996 Aug 17;348(9025):423-8.PMID: 8709780 [PubMed - indexed for MEDLINE]Related articles